Cutler Group LP Eagle Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 07, 2020	SELL	$34.37 - $60.07 $261,211 - $456,532	-7,600 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$54.32 - $64.31 $537,768 - $636,669	-9,900 Reduced 56.57%	7,600 $40,000
Q3 2018 Nov 07, 2018	SELL	$66.65 - $83.86 $906,440 - $1.14 Million	-13,600 Reduced 43.73%	17,500 $35,000
Q2 2018 Aug 10, 2018	BUY	$51.25 - $76.62 $1.27 Million - $1.9 Million	24,800 Added 393.65%	31,100 $151,000
Q4 2017 Jan 17, 2018	SELL	$49.6 - $60.87 $89,280 - $109,566	-1,800 Reduced 22.22%	6,300 $8,000
Q3 2017 Oct 17, 2017	BUY	$46.62 - $60.36 $377,622 - $488,916	8,100	8,100 $26,000

498K

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $19.4M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.